Correction: Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Amendment: Post-Transplant Autoimmune and Inflammatory Disorders Following Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis by the EBMT Working Groups on Transplant Complications and Autoimmune Conditions

  • By

  • Arsene Mekinian

  • Artem Oganesyan

  • Zinaida Perić

  • Myriam Labopin

  • Urpu Salmenniemi

  • José Antonio Pérez Simón

  • Anke Verlinden

  • Ioanna Sakellari

  • Mohsen Alzahrani

  • Massimo Martino

  • Frédéric Baron

  • John A. Snowden

  • Hakan Ozdogu

  • Alexander Kulagin

  • Edgar Jost

  • Anna Torrent

  • Fabio Benedetti

  • Anna De Becker

  • Sylvie François

  • Montserrat Rovira

  • Hans Christian Reinhardt

  • Alessandra Biffi

  • Mark Ringhoffer

  • Pascal Ambron

  • Jose Luis López Lorenzo

  • Nabil Yafour

  • Alexandre Galvagni

  • Manuela Badoglio

  • Ivan Moiseev

  • Tobias Alexander

  • Mohamad Mohty

  • Olivier Fain

  • Raffaella Greco

  • Olaf Penack

  • September 25, 2026

Share

Clinical Scorecard: Amendment: Post-Transplant Autoimmune and Inflammatory Disorders Following Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis by the EBMT Working Groups on Transplant Complications and Autoimmune Conditions

At a Glance

CategoryDetail
ConditionPost-Transplant Autoimmune and Inflammatory Disorders
Key MechanismsAutoimmune and inflammatory responses following allogeneic hematopoietic stem cell transplantation
Target PopulationPatients undergoing allogeneic hematopoietic stem cell transplantation
Care SettingBone Marrow Transplantation

Key Highlights

  • Correction of the article title to reflect the EBMT Complications Working Party
  • Focus on secondary autoimmune and inflammatory diseases post-transplant
  • Retrospective analysis conducted by the EBMT transplant complications working parties

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Patients post-allogeneic hematopoietic stem cell transplantation

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Correction: Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties

            • by Arsene Mekinian, Artem Oganesyan, Zinaida Perić, Myriam Labopin, Urpu Salmenniemi, José Antonio Pérez Simón, Anke Verlinden, Ioanna Sakellari, Mohsen Alzahrani, Massimo Martino, Frédéric Baron, John A. Snowden, Hakan Ozdogu, Alexander Kulagin, Edgar Jost, Anna Torrent, Fabio Benedetti, Anna De Becker, Sylvie François, Montserrat Rovira, Hans Christian Reinhardt, Alessandra Biffi, Mark Ringhoffer, Pascal Ambron, Jose Luis López Lorenzo, Nabil Yafour, Alexandre Galvagni, Manuela Badoglio, Ivan Moiseev, Tobias Alexander, Mohamad Mohty, Olivier Fain, Raffaella Greco, Olaf Penack

            • September 25, 2026

            Related Content

            CRISPR-Based Delivery System Generates CAR T Cells In Vivo

            A two-vector delivery system generates tumor-targeting CAR T cells directly inside the body, achieving complete responses in mouse cancer models

            • October 13, 2026

            • 3 min
            Bringing CAR T Closer to Home

            CAR T Vision aims to widen access to cell therapy by expanding community-based delivery, easing operational barriers, and building sustainable funding models

            • October 13, 2026

            • 8 min
            Immune and cellular determinants of response to HMA-venetoclax regimens in acute myeloid leukemia